333 related articles for article (PubMed ID: 21615391)
1. Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus.
Neuhold S; Resl M; Huelsmann M; Strunk G; Adlbrecht C; Rath C; Prager R; Luger A; Clodi M; Pacher R
Eur J Clin Invest; 2011 Dec; 41(12):1292-8. PubMed ID: 21615391
[TBL] [Abstract][Full Text] [Related]
2. Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.
Bertoni AG; Wagenknecht LE; Kitzman DW; Marcovina SM; Rushing JT; Espeland MA;
Obesity (Silver Spring); 2012 Jul; 20(7):1511-8. PubMed ID: 21959345
[TBL] [Abstract][Full Text] [Related]
3. A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitus.
Clodi M; Resl M; Neuhold S; Hülsmann M; Vila G; Elhenicky M; Strunk G; Abrahamian H; Prager R; Luger A; Pacher R
Eur J Prev Cardiol; 2012 Oct; 19(5):944-51. PubMed ID: 21856715
[TBL] [Abstract][Full Text] [Related]
4. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
Hamano K; Abe M; Komi R; Kobayashi S
Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
[TBL] [Abstract][Full Text] [Related]
6. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.
Resl M; Clodi M; Neuhold S; Kromoser H; Riedl M; Vila G; Prager R; Pacher R; Strunk G; Luger A; Hülsmann M
Diabet Med; 2012 Jun; 29(6):721-5. PubMed ID: 22050532
[TBL] [Abstract][Full Text] [Related]
7. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
Tarnow L; Gall MA; Hansen BV; Hovind P; Parving HH
Diabetologia; 2006 Oct; 49(10):2256-62. PubMed ID: 16937127
[TBL] [Abstract][Full Text] [Related]
8. NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus.
Malachias MVB; Jhund PS; Claggett BL; Wijkman MO; Bentley-Lewis R; Chaturvedi N; Desai AS; Haffner SM; Parving HH; Prescott MF; Solomon SD; De Zeeuw D; McMurray JJV; Pfeffer MA
J Am Heart Assoc; 2020 Oct; 9(19):e017462. PubMed ID: 32964800
[TBL] [Abstract][Full Text] [Related]
9. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
Price AH; Welsh P; Weir CJ; Feinkohl I; Robertson CM; Morling JR; McLachlan S; Strachan MW; Sattar N; Price JF
Diabetologia; 2014 Dec; 57(12):2505-12. PubMed ID: 25231020
[TBL] [Abstract][Full Text] [Related]
11. Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis.
Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29275373
[TBL] [Abstract][Full Text] [Related]
12. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
Grauslund J; Nybo M; Green A; Sjølie AK
Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
[TBL] [Abstract][Full Text] [Related]
13. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
Eggers KM; Venge P; Lind L
Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
[TBL] [Abstract][Full Text] [Related]
14. Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus.
Prausmüller S; Resl M; Arfsten H; Spinka G; Wurm R; Neuhold S; Bartko PE; Goliasch G; Strunk G; Pavo N; Clodi M; Hülsmann M
Cardiovasc Diabetol; 2021 Feb; 20(1):34. PubMed ID: 33530999
[TBL] [Abstract][Full Text] [Related]
15. Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction.
Pastormerlo LE; Mammini C; Giannoni A; Valleggi A; Prontera C; Gabutti A; Poletti R; Padeletti L; Emdin M; Passino C
J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):423-30. PubMed ID: 25083720
[TBL] [Abstract][Full Text] [Related]
16. Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
Januzzi JL; Xu J; Li J; Shaw W; Oh R; Pfeifer M; Butler J; Sattar N; Mahaffey KW; Neal B; Hansen MK
J Am Coll Cardiol; 2020 Nov; 76(18):2076-2085. PubMed ID: 33121714
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
18. Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.
Xu L; Chan WM; Hui YF; Lam TH
Diabet Med; 2012 Mar; 29(3):393-8. PubMed ID: 21916977
[TBL] [Abstract][Full Text] [Related]
19. Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.
Andersson C; van Gaal L; Caterson ID; Weeke P; James WP; Coutinho W; Finer N; Sharma AM; Maggioni AP; Torp-Pedersen C
Diabetologia; 2012 Sep; 55(9):2348-55. PubMed ID: 22638548
[TBL] [Abstract][Full Text] [Related]
20. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
